Nasal spray with exosomes and anti-inflammatory medicines for chronic sinusitis
Part of Ear, nose & throat clinical trials.
This trial tests a new nasal spray that combines exosomes (tiny cell messengers), azelastine (an antihistamine), and interferon (a protein that helps fight infections) for people with chronic sinusitis. It aims to reduce symptoms and improve your sinus condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have had chronic sinusitis for more than 12 weeks.
- Your symptoms must be stable in the last month, or if you have a flare-up, it must not require strong antibiotics or steroid pills.
- You must not have used steroid nasal sprays, antihistamines, or other allergy medications in the past 2 weeks.
- You must not have nasal polyps, have had sinus surgery in the last 6 months, or have serious health problems like diabetes, high blood pressure, or an autoimmune disease.
- You must be willing to give your written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special nasal spray gel that combines stem cell exosomes, an antibiotic, and an enzyme to treat chronic sinusitis caused by staph bacteria. It aims to reduce infection and improve symptoms like nasal blockage and discharge.
This trial tests an experimental tablet (HTMC0658) for people with chronic sinusitis that hasn't improved with standard nasal spray. You may join if your symptoms are moderate to severe and you've been using a stable dose of mometasone spray for at least 4 weeks.
This study tests a new nasal spray (OPN-375) for teens aged 12–17 with chronic sinusitis but without nasal polyps. It aims to see if the spray improves symptoms like congestion and runny nose.
This trial tests a more thorough sinus surgery combined with removing lymphoid tissue in the throat to see if it helps people with nasal polyps. Researchers want to know if this approach reduces inflammation and improves symptoms.
This trial tests a medication called tezepelumab to see if it can improve symptoms for people with chronic sinusitis and nasal polyps who also have severe asthma. It may help reduce inflammation and improve breathing and nasal symptoms.
This trial tests a nasal spray called Bactorinol combined with a lower dose of a standard steroid (mometasone) to treat chronic sinusitis. It aims to see if the combination reduces symptoms and is safe and well-tolerated.
Hear when a new Chronic Rhinosinusitis Without Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.